Shawna Williams

Shawna Williams

Contract Editor

Shawna is an editor and writer with a background in covering the life sciences. Previously, she was an editor at The Scientist from 2017 through 2022, where she served as news director for the last year and a half of her tenure. She has also worked as a freelance editor and writer and in the communications offices of several academic research institutions, and is a member of the National Association of Science Writers and the Association of Health Care Journalists. She is based in New York City, where she enjoys exploring the city’s restaurants, studying tae kwon do, and taking her kids to the library. She can be reached at shawna.williams@biospace.com. Learn more about her work at shawnawilliams.com.

Multiple players are exploring whether modalities designed to combat B cell malignancies can be repurposed against lupus, myasthenia gravis and other conditions traced to misdirected immune response.
The recent FDA decision will likely mean more Medicare patients gain access to the blockbuster weight loss drug, experts say. Meanwhile, results continue to roll in for GLP-1 agonists for conditions beyond diabetes and obesity.
Patient advocacy groups aided in the development of the very first marketed drugs for certain rare diseases, including progeria and Friedreich’s ataxia.
A proposed class-action lawsuit accuses Johnson & Johnson of failing to negotiate fair prescription drug prices for its employees, but experts note that the company is also on the hook for benefits costs.
People who worked in the industry around the time that BioSpace launched its Hotbeds Maps—including Marc Goldberg, a MassBio co-founder, and Biocom leader Joe Panetta—spoke with us about their experiences.
The Gates Foundation and some biotechs are betting that the technology could be deployed at scale.
The United States’ relatively high costs have become a political issue on both sides of the aisle. Here’s how international pharmaceutical prices stack up.
BioSpace spoke with representatives of the two top-place finishers in our Best Places to Work list about their approaches to fostering an engaging workplace.
The pharmaceutical giant aims to hire another 50 people by the end of this year to work on a new platform dedicated to harnessing data and AI insights in drug discovery.
Employers in the industry find they need to offer perks such as higher pay, more impressive job titles and hybrid or remote work to stay competitive.
Both public and private programs aim to help veterans apply their skills in the biotech and pharmaceutical sector.
For over three years, no interest has accrued on federal student loans and no payments were required. Soon, mandatory payments will resume, leaving workers with less money in the bank.
The industry, seen as a lucrative target, has been victim of more and more cybersecurity breaches since the start of the COVID-19 pandemic.
Clinical lab techs are in high demand in healthcare, pharma and biotech. Here’s a look at what they do, career advancement opportunities within the role and the training required to become one.
When a person notifies their employer that they have a disability, the company must make a good-faith effort to adjust to enable the employee to continue in their job.